Title:
An open, randomized-controlled, multi-center phase-II clinical trial of individualized immunosuppression with intravenously administered donor modified immune cells (MICs) compared to standard-of-care after living donor kidney transplantation.
Phase:
II
Contact:
Max Wingbermühle / Kontaktperson
Email-Address:
Max.Wingbermuehle@med.uni-heidelberg.de
Clinical Investigator:
PD Dr. med. Anita Schmitt
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT05365672
EudraCT-Number:
Siehe EU klinisches Studienregister
2021-000561-33